179 related articles for article (PubMed ID: 5688054)
1. Effect of podophyllum products S.P.I.&S.P.G. on malignant diseases.
Datta H; Biswas S
Indian J Cancer; 1968 Jun; 5(2):152-9. PubMed ID: 5688054
[No Abstract] [Full Text] [Related]
2. [On the effect of combined therapy with SP-I Sandoz and radiation in experimental sarcoma 37 in mice].
Benz A
Dermatologica; 1968; 136(5):368-82. PubMed ID: 5662281
[No Abstract] [Full Text] [Related]
3. [Cancer of the esophagus: treatment with the cytostatic agents SP-G and SP-I].
Guida Filho B; Mirra AP
Rev Paul Med; 1968 Feb; 72(2):49-54. PubMed ID: 5739063
[No Abstract] [Full Text] [Related]
4. [Clinical studies of the method of application of antineoplastic agents].
Furue H; Nakao I; Hattori T; Yamana T; Kubo A
Gan No Rinsho; 1970 Sep; 16(9):896-909. PubMed ID: 5528959
[No Abstract] [Full Text] [Related]
5. Synergistic antitumor effects of an ethylhydrazide derivative of podophyllic acid combined with x-rays.
Goldenberg DM; Ammersdörfer E
Arzneimittelforschung; 1970 Jun; 20(6):789-90. PubMed ID: 5468894
[No Abstract] [Full Text] [Related]
6. Analysis of the results of regional chemotherapy for carcinomas of the orofacial region.
Bilder J; Hornová J
Neoplasma; 1970; 17(1):85-92. PubMed ID: 5447247
[No Abstract] [Full Text] [Related]
7. [Treatment of malignant tumors with SP-I/SP-G Sandoz (Proresid)].
Bîrzu I
Ther Umsch; 1966 Dec; 23(12):522-7. PubMed ID: 5980440
[No Abstract] [Full Text] [Related]
8. Adjuvant cancer chemotherapy. Development of a dosage schedule for the adjuvant cancer chemotherapy in surgical cases.
Larsen V; Brockner J; Storm O
Acta Chir Scand Suppl; 1965; 343():202-8. PubMed ID: 4158083
[No Abstract] [Full Text] [Related]
9. [Experimental bases and clinical aspects of the use of 2 antimitotic derivatives of podophyllum].
Fanchamps A
J Med (Oporto); 1965 Nov; 58(191):673-92. PubMed ID: 5215285
[No Abstract] [Full Text] [Related]
10. SPI and SPG in the treatment of advanced malignant lesions.
Grewal TS; Samual KC; Sachdev DL; Rastogi DC
Int Surg; 1967 Oct; 48(4):360-7. PubMed ID: 6050546
[No Abstract] [Full Text] [Related]
11. [Chemical constitution and teratogenic effect in rats. 3. N-alkylcarbonhydrazides, hydrazine derivatives].
von Kreybig T; Preussmann R; von Kreybig I
Arzneimittelforschung; 1970 Mar; 20(3):363-7. PubMed ID: 5467510
[No Abstract] [Full Text] [Related]
12. [5-year results of combined treatment with the cobalt bomb and the cytostatic preparation SP-G and SP-I (Sandoz)].
Hubacher O
Dtsch Med Wochenschr; 1965 Nov; 90(48):2145-9. PubMed ID: 5844793
[No Abstract] [Full Text] [Related]
13. [Comparative results of massive endoxan stoss therapy and treatment of malignant tumors with proresid].
Gebhardt KH; Becher R
Med Welt; 1967 Jul; 30():1705-7. PubMed ID: 5616405
[No Abstract] [Full Text] [Related]
14. [Chemotherapy of bronchila cancer. Monotherapy and combination therapy].
Beumer HM
Med Klin; 1968 Apr; 63(17):676-8 passim. PubMed ID: 5682018
[No Abstract] [Full Text] [Related]
15. [Immunosuppressive treatment of progressive chronic polyarthritis. Experiences with an antimitotic drug from the podophyllin series (Proresid)].
Chlud K; Prohaska E; Zeitlhofer J; Pfaller C; Friza B
Munch Med Wochenschr; 1968 Jan; 110(2):88-97. PubMed ID: 5695131
[No Abstract] [Full Text] [Related]
16. [Treatment of chronic connective tissue diseases with cytostatics].
Deicher H; Fricke R; Krull P
Minerva Med; 1970 Jul; 61(55):3040-53. PubMed ID: 4987808
[No Abstract] [Full Text] [Related]
17. [The effect of Proresid on the growth and formation of metastases of the RBI-sarcoma in rats].
Svec F; Altaner C
Med Klin; 1968 Dec; 63(52):2119-25. PubMed ID: 5729222
[No Abstract] [Full Text] [Related]
18. [Clinical findings in podophyllotoxin derivatives (SP-I-SP-G) in malignant tumors].
Ohara H; Noto J; Kihara A; Noguchi H; Ishii Y
Gan No Rinsho; 1968 Feb; 14(2):96-100. PubMed ID: 5244790
[No Abstract] [Full Text] [Related]
19. [Considerations on the use of Proresid (SPI-SPG Sandoz) as an adjuvant in the treatment of tumors (preliminart communication)].
Motti VJ
Hospital (Rio J); 1968 Oct; 74(4):1377-88. PubMed ID: 5304166
[No Abstract] [Full Text] [Related]
20. [Immunosuppressive agents in multiple sclerosis. Preliminary trials with Proresid].
Danielczyk W
Wien Med Wochenschr; 1968 Nov; 118(44):934-7. PubMed ID: 5710171
[No Abstract] [Full Text] [Related]
[Next] [New Search]